NCT00301613View on ClinicalTrials.gov

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

May 31, 2005

Study Completion Date

January 31, 2006

Conditions
Henoch-Schoenlein PurpuraNephritis
Interventions
DRUG

Mycophenolate mofetil

MMF,1.0g/d

Trial Locations (1)

210002

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing

All Listed Sponsors
lead

Nanjing University School of Medicine

OTHER

NCT00301613 - Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN | Biotech Hunter | Biotech Hunter